A Phase 1 Trial of Fuzuloparib in Combination with Apatinib for Advanced Ovarian and Triple-Negative Breast Cancer: Efficacy, Safety, Pharmacokinetics and Germline BRCA Mutation Analysis
BMC MEDICINE（2023）
关键词
Ovarian cancer,Triple-negative breast cancer,PARP inhibitor,Anti-angiogenic therapy,gBRCA
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要